by Maria Zannes | Nov 15, 2023 | Press Releases
SAN ANTONIO, Texas (Nov. 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today launched a campaign in partnership...
by Maria Zannes | Nov 14, 2023 | Press Releases
SAN ANTONIO, Texas (Nov. 14, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...
by Maria Zannes | Nov 8, 2023 | Articles, News
The latest move is a key step for an Alamo City company pursuing widespread adoption of its core technology. As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Nov. 6, 2023 San Antonio-based bioAffinity...
by Maria Zannes | Nov 6, 2023 | Press Releases
SAN ANTONIO, Texas (Nov. 6, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced the appointment of Dallas J....
by Maria Zannes | Oct 10, 2023 | Press Releases
CEO Maria Zannes to hold one-on-one investor meetings and present a corporate update highlighting commercial strategy SAN ANTONIO, Texas (Oct. 10, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for...
